{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:20:27Z","timestamp":1758925227509,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10637-019-00800-9","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T02:02:33Z","timestamp":1559527353000},"page":"547-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of chemotherapy on placental development and function using in vitro culture of human primary cytotrophoblasts"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2826-3075","authenticated-orcid":false,"given":"Christophe Louis","family":"Depoix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Colson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Mhallem-Gziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Hubinont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Debieve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"issue":"4","key":"800_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","volume":"7","author":"NA Pavlidis","year":"2002","unstructured":"Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7(4):279\u2013287","journal-title":"Oncologist"},{"issue":"2","key":"800_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0163-7258(97)82004-9","volume":"74","author":"U Ebert","year":"1997","unstructured":"Ebert U, Loffler H, Kirch W (1997) Cytotoxic therapy and pregnancy. Pharmacol Ther 74(2):207\u2013220","journal-title":"Pharmacol Ther"},{"issue":"38","key":"800_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004899","volume":"95","author":"S Esposito","year":"2016","unstructured":"Esposito S, Tenconi R, Preti V, Groppali E, Principi N (2016) Chemotherapy against cancer during pregnancy: a systematic review on neonatal outcomes. Medicine (Baltimore) 95(38):e4899. https:\/\/doi.org\/10.1097\/MD.0000000000004899","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"800_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","volume":"28","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, Halaska M, Vergote I, Ottevanger N, Amant F (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683\u2013689. https:\/\/doi.org\/10.1200\/JCO.2009.23.2801","journal-title":"J Clin Oncol"},{"key":"800_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-7827-2-15","volume":"2","author":"R Soundararajan","year":"2004","unstructured":"Soundararajan R, Rao AJ (2004) Trophoblast \u201cpseudo-tumorigenesis\u201d: significance and contributory factors. Reprod Biol Endocrinol 2:15. https:\/\/doi.org\/10.1186\/1477-7827-2-15","journal-title":"Reprod Biol Endocrinol"},{"issue":"12","key":"800_CR6","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s11095-016-2028-8","volume":"33","author":"AA Joshi","year":"2016","unstructured":"Joshi AA, Vaidya SS, St-Pierre MV, Mikheev AM, Desino KE, Nyandege AN, Audus KL, Unadkat JD, Gerk PM (2016) Placental ABC transporters: biological impact and pharmaceutical significance. Pharm Res 33(12):2847\u20132878. https:\/\/doi.org\/10.1007\/s11095-016-2028-8","journal-title":"Pharm Res"},{"issue":"10","key":"800_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/qjmed\/92.10.551","volume":"92","author":"ME Lloyd","year":"1999","unstructured":"Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA (1999) The effects of methotrexate on pregnancy, fertility and lactation. QJM 92(10):551\u2013563","journal-title":"QJM"},{"issue":"8","key":"800_CR8","first-page":"1872","volume":"27","author":"M Ostensen","year":"2000","unstructured":"Ostensen M, Hartmann H, Salvesen K (2000) Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 27(8):1872\u20131875","journal-title":"J Rheumatol"},{"issue":"12","key":"800_CR9","first-page":"2360","volume":"31","author":"B Lewden","year":"2004","unstructured":"Lewden B, Vial T, Elefant E, Nelva A, Carlier P, Descotes J, French Network of Regional Pharmacovigilance C (2004) Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study. J Rheumatol 31(12):2360\u20132365","journal-title":"J Rheumatol"},{"issue":"7","key":"800_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/jcp.55.7.514","volume":"55","author":"MJ Mourits","year":"2002","unstructured":"Mourits MJ, Ten Hoor KA, van der Zee AG, Willemse PH, de Vries EG, Hollema H (2002) The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol 55(7):514\u2013519","journal-title":"J Clin Pathol"},{"issue":"3","key":"800_CR11","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1124\/jpet.104.065607","volume":"310","author":"Z Desta","year":"2004","unstructured":"Desta Z, Ward BA, Soukhova NV, Flockhart DA (2004) Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther 310(3):1062\u20131075. https:\/\/doi.org\/10.1124\/jpet.104.065607","journal-title":"J Pharmacol Exp Ther"},{"key":"800_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10549-019-05154-7","volume":"175","author":"TN Schuurman","year":"2019","unstructured":"Schuurman TN, Witteveen PO, van der Wall E, Passier JLM, Huitema ADR, Amant F, Lok CAR (2019) Tamoxifen and pregnancy: an absolute contraindication? Breast Cancer Res Treat 175:17\u201325. https:\/\/doi.org\/10.1007\/s10549-019-05154-7","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"800_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/molehr\/6.8.743","volume":"6","author":"F Debieve","year":"2000","unstructured":"Debieve F, Pampfer S, Thomas K (2000) Inhibin and activin production and subunit expression in human placental cells cultured in vitro. Mol Hum Reprod 6(8):743\u2013749","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"800_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671\u2013675","journal-title":"Nat Methods"},{"issue":"Suppl 1","key":"800_CR15","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.3816\/CBC.2003.s.012","volume":"4","author":"VG Kaklamani","year":"2003","unstructured":"Kaklamani VG, Gradishar WJ (2003) Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer? Clin Breast Cancer 4(Suppl 1):S26\u2013S33","journal-title":"Clin Breast Cancer"},{"issue":"14","key":"800_CR16","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","volume":"23","author":"DR Liston","year":"2017","unstructured":"Liston DR, Davis M (2017) Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies. Clin Cancer Res 23(14):3489\u20133498. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3083","journal-title":"Clin Cancer Res"},{"issue":"4","key":"800_CR17","first-page":"291","volume":"3","author":"HH Ho","year":"1997","unstructured":"Ho HH, Douglas GC, Qiu QF, Thirkill TL, Overstreet JW, Lasley BL (1997) The relationship between trophoblast differentiation and the production of bioactive hCG. Early Pregnancy 3(4):291\u2013300","journal-title":"Early Pregnancy"},{"key":"800_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10456-008-9114-4","volume":"11","author":"D Ribatti","year":"2008","unstructured":"Ribatti D (2008) The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis 11:215\u2013221","journal-title":"Angiogenesis"},{"issue":"9","key":"800_CR19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/mrd.22209","volume":"80","author":"F Debieve","year":"2013","unstructured":"Debieve F, Depoix C, Gruson D, Hubinont C (2013) Reversible effects of oxygen partial pressure on genes associated with placental angiogenesis and differentiation in primary-term cytotrophoblast cell culture. Mol Reprod Dev 80(9):774\u2013784. https:\/\/doi.org\/10.1002\/mrd.22209","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"800_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/01635581.2014.894093","volume":"66","author":"KK Auyeung","year":"2014","unstructured":"Auyeung KK, Law PC, Ko JK (2014) Combined therapeutic effects of vinblastine and Astragalus saponins in human colon cancer cells and tumor xenograft via inhibition of tumor growth and proangiogenic factors. Nutr Cancer 66(4):662\u2013674. https:\/\/doi.org\/10.1080\/01635581.2014.894093","journal-title":"Nutr Cancer"},{"issue":"4","key":"800_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/bdd.2510020407","volume":"2","author":"C Fabian","year":"1981","unstructured":"Fabian C, Tilzer L, Sternson L (1981) Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer. Biopharm Drug Dispos 2(4):381\u2013390","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"800_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/toxsci\/54.1.138","volume":"54","author":"RM Blair","year":"2000","unstructured":"Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM (2000) The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci 54(1):138\u2013153","journal-title":"Toxicol Sci"},{"issue":"6","key":"800_CR23","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.ajpath.2012.02.026","volume":"180","author":"M Helmestam","year":"2012","unstructured":"Helmestam M, Andersson H, Stavreus-Evers A, Brittebo E, Olovsson M (2012) Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells. Am J Pathol 180(6):2527\u20132535. https:\/\/doi.org\/10.1016\/j.ajpath.2012.02.026","journal-title":"Am J Pathol"},{"issue":"4","key":"800_CR24","first-page":"1652","volume":"61","author":"I Bieche","year":"2001","unstructured":"Bieche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R, Vidaud M (2001) Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 61(4):1652\u20131658","journal-title":"Cancer Res"},{"issue":"1","key":"800_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1677\/jme.0.0110091","volume":"11","author":"SC Sharma","year":"1993","unstructured":"Sharma SC, Purohit P, Rao AJ (1993) Role of oestradiol-17 beta in the regulation of synthesis and secretion of human chorionic gonadotrophin by first trimester human placenta. J Mol Endocrinol 11(1):91\u2013101","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"800_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1053\/plac.1999.0423","volume":"20","author":"L Cronier","year":"1999","unstructured":"Cronier L, Guibourdenche J, Niger C, Malassine A (1999) Oestradiol stimulates morphological and functional differentiation of human villous cytotrophoblast. Placenta 20(8):669\u2013676. https:\/\/doi.org\/10.1053\/plac.1999.0423","journal-title":"Placenta"},{"issue":"8","key":"800_CR27","first-page":"3458","volume":"61","author":"M Maliepaard","year":"2001","unstructured":"Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61(8):3458\u20133464","journal-title":"Cancer Res"},{"issue":"5","key":"800_CR28","doi-asserted-by":"publisher","first-page":"R1357","DOI":"10.1152\/ajpregu.00630.2005","volume":"290","author":"DA Evseenko","year":"2006","unstructured":"Evseenko DA, Paxton JW, Keelan JA (2006) ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 290(5):R1357\u2013R1365. https:\/\/doi.org\/10.1152\/ajpregu.00630.2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"800_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/jjco\/hyw073","volume":"46","author":"S Miyamoto","year":"2016","unstructured":"Miyamoto S, Yamada M, Kasai Y, Miyauchi A, Andoh K (2016) Anticancer drugs during pregnancy. Jpn J Clin Oncol 46(9):795\u2013804. https:\/\/doi.org\/10.1093\/jjco\/hyw073","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"800_CR30","doi-asserted-by":"publisher","first-page":"E118","DOI":"10.1208\/aapsj070112","volume":"7","author":"Q Mao","year":"2005","unstructured":"Mao Q, Unadkat JD (2005) Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J 7(1):E118\u2013E133. https:\/\/doi.org\/10.1208\/aapsj070112","journal-title":"AAPS J"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00800-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-019-00800-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00800-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:45:19Z","timestamp":1678560319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-019-00800-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s10637-019-00800-9","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"type":"print","value":"0167-6997"},{"type":"electronic","value":"1573-0646"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"28 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Christophe Louis Depoix declares that he has no conflict of interest. Arthur Colson declares that he has no conflict of interest. Mina Mhallem-Gziri declares that she has no conflict of interest. Corinne Hubinont declares that she has no conflict of interest. Fr\u00e9d\u00e9ric Debi\u00e8ve declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving our participants were in accordance with the ethical standards of the CUSL and Research Ethics Committee (approval # 2018-23OCT-397) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}